British American Tobacco, a British multinational company, agreed to acquire a 19.9% stake in Organigram, a medical marijuana company, for $176m. “We have been extremely selective about aligning with a strategic partner and, in BAT, we’ve found a leading consumer goods business with innovative product platforms, an impressive dedication to research and development, deep consumer insights, regulatory expertise and a commitment to responsible stewardship and consumer safety," Greg Engel, Organigram CEO.